These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15470077)

  • 1. Increased natural killer cell activity in viremic HIV-1 infection.
    Alter G; Malenfant JM; Delabre RM; Burgett NC; Yu XG; Lichterfeld M; Zaunders J; Altfeld M
    J Immunol; 2004 Oct; 173(8):5305-11. PubMed ID: 15470077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.
    Mavilio D; Lombardo G; Benjamin J; Kim D; Follman D; Marcenaro E; O'Shea MA; Kinter A; Kovacs C; Moretta A; Fauci AS
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2886-91. PubMed ID: 15699323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
    Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity.
    Azzoni L; Papasavvas E; Chehimi J; Kostman JR; Mounzer K; Ondercin J; Perussia B; Montaner LJ
    J Immunol; 2002 Jun; 168(11):5764-70. PubMed ID: 12023377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection.
    Eller MA; Eller LA; Ouma BJ; Thelian D; Gonzalez VD; Guwatudde D; McCutchan FE; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK
    J Acquir Immune Defic Syndr; 2009 Aug; 51(4):380-9. PubMed ID: 19487954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential production of IFN-gamma, analyzed at the single-cell level, by specific subsets of human NK and T cells from healthy and HIV(+) subjects.
    Vitale M; Caruso A; Licenziati S; Rodella L; Fiorentini S; Zauli G; Castelli F; Manzoli FA; Turano A
    Cytometry; 2000 Mar; 39(3):189-94. PubMed ID: 10685075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.
    Pohlmeyer CW; Gonzalez VD; Irrinki A; Ramirez RN; Li L; Mulato A; Murry JP; Arvey A; Hoh R; Deeks SG; Kukolj G; Cihlar T; Pflanz S; Nolan GP; Min-Oo G
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
    Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.
    Conry SJ; Milkovich KA; Yonkers NL; Rodriguez B; Bernstein HB; Asaad R; Heinzel FP; Tary-Lehmann M; Lederman MM; Anthony DD
    J Virol; 2009 Nov; 83(21):11175-87. PubMed ID: 19692459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV.
    Zarife MA; Reis EA; Carmo TM; Lopes GB; Brandão EC; Silva HR; Santana N; Martins-Filho OA; Reis MG
    J Med Virol; 2009 Jan; 81(1):49-59. PubMed ID: 19031471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C.
    Kokordelis P; Krämer B; Boesecke C; Voigt E; Ingiliz P; Glässner A; Wolter F; Srassburg CP; Spengler U; Rockstroh JK; Nattermann J
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):338-46. PubMed ID: 26509931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-15 enhances the secretion of IFN-gamma and CC chemokines by natural killer cells from HIV viremic and aviremic patients.
    d'Ettorre G; Andreotti M; Carnevalini M; Andreoni C; Zaffiri L; Vullo V; Vella S; Mastroianni CM
    Immunol Lett; 2006 Mar; 103(2):192-5. PubMed ID: 16289324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of NK cells is associated with HIV-1 disease progression.
    Kuri-Cervantes L; de Oca GS; Avila-Ríos S; Hernández-Juan R; Reyes-Terán G
    J Leukoc Biol; 2014 Jul; 96(1):7-16. PubMed ID: 24399837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-γ production by tubulointerstitial human CD56
    Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
    Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.
    Milush JM; López-Vergès S; York VA; Deeks SG; Martin JN; Hecht FM; Lanier LL; Nixon DF
    Retrovirology; 2013 Dec; 10():158. PubMed ID: 24351015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals.
    Montoya CJ; Velilla PA; Chougnet C; Landay AL; Rugeles MT
    Clin Immunol; 2006 Aug; 120(2):138-46. PubMed ID: 16624619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.
    Dillon SM; Lee EJ; Bramante JM; Barker E; Wilson CC
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):259-67. PubMed ID: 24091697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.
    Goodier MR; Imami N; Moyle G; Gazzard B; Gotch F
    Clin Exp Immunol; 2003 Dec; 134(3):470-6. PubMed ID: 14632753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD107a as a functional marker for the identification of natural killer cell activity.
    Alter G; Malenfant JM; Altfeld M
    J Immunol Methods; 2004 Nov; 294(1-2):15-22. PubMed ID: 15604012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic and natural killer cell subsets associated with stable or declining CD4+ cell counts in treated HIV-1-infected children.
    Azzoni L; Rutstein RM; Chehimi J; Farabaugh MA; Nowmos A; Montaner LJ
    J Infect Dis; 2005 May; 191(9):1451-9. PubMed ID: 15809903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.